Vivo Bio Tech Limited (BOM:511509)
India · Delayed Price · Currency is INR 37.43
-0.36 (-0.95%)
At close: Sep 10, 2025
Vivo Bio Tech Revenue
Vivo Bio Tech had revenue of 125.12M INR in the quarter ending June 30, 2025, with 23.46% growth. This brings the company's revenue in the last twelve months to 490.50M, up 11.47% year-over-year. In the fiscal year ending March 31, 2025, Vivo Bio Tech had annual revenue of 466.73M with 2.69% growth.
Revenue (ttm)
490.50M
Revenue Growth
+11.47%
P/S Ratio
1.63
Revenue / Employee
2.82M
Employees
161
Market Cap
798.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 466.73M | 12.21M | 2.69% |
| Mar 31, 2024 | 454.51M | -67.79M | -12.98% |
| Mar 31, 2023 | 522.30M | 8.39M | 1.63% |
| Mar 31, 2022 | 513.91M | -3.84M | -0.74% |
| Mar 31, 2021 | 517.75M | -35.77M | -6.46% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Hindustan Unilever | 639.28B |
| Infosys | 1,672.76B |